Antitumor Activity of a Synthetic Small RNA Based on a Maytenus hookeri Sequence in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177601 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dengyuan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Bas…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer-related mortality worldwide, highlighting the urgent need for novel therapeutic strategies. This study aimed to identify bioactive small RNAs derived from Maytenus hookeri Loes. and evaluate their anti-tumor potential against non-small cell lung cancer (NSCLC). The 50 most abundant small RNAs were synthesized and screened in NCI-H460 cells using the MTS assay. Among them, MDM-sRNA-39 significantly inhibited cell viability and was selected for further evaluation of its anti-tumor activity. It reduced the percentage of cells that traversed the Transwell membrane and promoted apoptosis in NCI-H460 cells. Bioinformatics prediction suggested KRAS as a potential target of MDM-sRNA-39, and KRAS was among the targets experimentally validated by dual-luciferase reporter assays, RT-qPCR, and Western blot, showing that MDM-sRNA-39 suppresses KRAS expression at both mRNA and protein levels. In vivo, MDM-sRNA-39 was orally administered as a bencaosome in a KrasLSL-G12D/p53LoxP/LoxP autochthonous lung cancer mouse model. Tumor burden was reduced and cleaved caspase-3 staining was increased in the mouse model. Collectively, these findings identify MDM-sRNA-39, a synthetic small RNA based on a sequence identified from Maytenus hookeri Loes., as a candidate with anti-tumor activity, supporting the potential strategy for developing RNA-based therapeutics from traditional Chinese medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medica…
ORCID-Profile: Dengyuan Liu, Na Sun
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Liu, D., Yang, X., Du, S., Sun, N., Lin, Y., Dong, Y., & Jiang, C. (2026). Antitumor Activity of a Synthetic Small RNA Based on a Maytenus hookeri Sequence in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177601
Vancouver
Liu D, Yang X, Du S, Sun N, Lin Y, Dong Y, et al. Antitumor Activity of a Synthetic Small RNA Based on a Maytenus hookeri Sequence in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177601
BibTeX
@article{Liu2026,
author = {Liu, Dengyuan and Yang, Xinmeng and Du, Sifen and Sun, Na and Lin, Yexuan and Dong, Yixin and Jiang, Chengyu},
title = {Antitumor Activity of a Synthetic Small RNA Based on a Maytenus hookeri Sequence in Non-Small Cell Lung Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177601}
}
EUVIMED